Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | NCF1 | P14598 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | PLG | P00747 | 1/20 | 0.35 |
| ▸ | PLAT | P00750 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26661 | 1.00 | EPHX2 (0.39) | EPHX2NCF1CYP2D6SIGMAR1PLG | |
| SCHEMBL1703645 | 1.00 | EPHX2 (0.39) | EPHX2NCF1CYP2D6SIGMAR1PLG | |
| SCHEMBL7135021 | 1.00 | EPHX2 (0.39) | EPHX2NCF1CYP2D6SIGMAR1PLG | |
| SCHEMBL1703647 | 1.00 | EPHX2 (0.39) | EPHX2NCF1CYP2D6SIGMAR1PLG | |
| Hydrochloric Acid SCHEMBL25223266 | 0.97 | EPHX2 (0.37) | EPHX2NCF1CYP2D6SIGMAR1PLG | |
| Ammonia Solution, Strong SCHEMBL9620353 | 0.97 | EPHX2 (0.37) | EPHX2NCF1CYP2D6SIGMAR1PLG | |
| Ammonia Solution, Strong SCHEMBL20562887 | 0.97 | EPHX2 (0.37) | EPHX2NCF1CYP2D6SIGMAR1PLG | |
| Hydrochloric Acid SCHEMBL9438734 | 0.97 | EPHX2 (0.37) | EPHX2NCF1CYP2D6SIGMAR1PLG | |
| SCHEMBL5249610 | 0.94 | PLG (0.42) | EPHX2NCF1CYP2D6SIGMAR1PLG | |
| SCHEMBL25602681 | 0.93 | CYP2D6 (0.41) | EPHX2NCF1CYP2D6SIGMAR1PLG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 272 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021103550-A1 | 1,3-BISISOCYANATOMETHYLCYCLOHEXANE COMPOSITION AND OPTICAL RESIN PREPARED THEREFROM | 万华化学集团股份有限公司 | 2021-06-03 | — | — | WO | claimed |
| CN-110982034-A | 1, 3-diisocyanatomethylcyclohexane composition and optical resin prepared from same | 万华化学集团股份有限公司 | 2020-04-10 | — | — | CN | claimed |
| EP-2094759-B1 | EPOXY RESINS COMPRISING A CYCLOALIPHATIC DIAMINE CURING AGENT | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-04-18 | — | — | EP | claimed |
| US-20100029894-A1 | POLYAMIDE POLYMER | DOW GLOBAL TECHNOLOGIES LLC | 2010-02-04 | — | — | US | claimed |
| EP-4739727-A1 | CURING AGENT COMPOSITION COMPRISING SALTS OF THIOCYANATE | Hilti Aktiengesellschaft (LI) | 2026-05-13 | — | — | EP | disclosed |
| US-12597655-B2 | Device for cooling and/or heating a battery of an electric or hybrid motor vehicle | ARKEMA FRANCE (FR) | 2026-04-07 | — | — | US | disclosed |
| EP-4702070-A1 | TWO-COMPONENT EPOXY SYSTEMS | Sika Technology AG (CH) | 2026-03-04 | — | — | EP | disclosed |
| US-20250376561-A1 | SHORT DIAMINE-BASED SEMI-CRYSTALLINE POLYAMIDE COMPOSITION HAVING A HIGH GLASS TRANSITION TEMPERATURE FOR A THERMOPLASTIC MATERIAL, PRODUCTION METHOD THEREOF AND USES OF SAME | ARKEMA FRANCE (FR) | 2025-12-11 | — | — | US | disclosed |
| US-20250297055-A1 | METHOD FOR PREPARING AN EPOXY-DERIVED COVALENT ADAPTABLE NETWORK | UNIVERSITEIT GENT (BE) | 2025-09-25 | — | — | US | disclosed |
| US-12371539-B2 | Use of a copolyamide composition as a matrix of filler material with glass fibres having a circular cross section for limiting warping | ARKEMA FRANCE (FR) | 2025-07-29 | — | — | US | disclosed |
| US-12344710-B2 | Semi-crystalline copolyamides, moulding compounds comprising same and their use, and mouldings manufactured from same | EMS-PATENT AG (CH) | 2025-07-01 | — | — | US | disclosed |
| EP-4557461-A2 | DEVICE FOR COOLING AND/OR HEATING A BATTERY OF AN ELECTRIC OR HYBRID MOTOR VEHICLE | ARKEMA FRANCE (FR) | 2025-05-21 | — | — | EP | disclosed |
| EP-1558659-A1 | POLYURETHANE DISPERSION AND ARTICLES PREPARED THEREFROM | DOW GLOBAL TECHNOLOGIES INC. (US) | 2005-08-03 | — | — | EP | disclosed |
| WO-2004041890-A9 | POLYURETHANE DISPERSION AND ARTICLES PREPARED THEREFROM | DOW GLOBAL TECHNOLOGIES INC (US) | 2004-07-22 | — | — | WO | disclosed |
| WO-2004041890-A1 | POLYURETHANE DISPERSION AND ARTICLES PREPARED THEREFROM | DOW GLOBAL TECHNOLOGIES INC. (US) | 2004-05-21 | — | — | WO | disclosed |
| WO-2004041899-A1 | POLYURETHANE COMPOUNDS AND ARTICLES PREPARED THEREFROM | DOW GLOBAL TECHNOLOGIES INC. (US) | 2004-05-21 | — | — | WO | disclosed |
| US-20030191134-A1 | Non-peptide somatostatin receptor ligands | SHAPIRO GIDEON (US) | 2003-10-09 | — | — | US | disclosed |
| EP-0780340-B1 | Intercalates and exfoliates formed with functional monomeric organic compounds; composite materials containing same and methods of modifying rheology therewith | AMCOL INTERNATIONAL CORP (US) | 2002-03-20 | — | — | EP | disclosed |
| US-6277911-B1 | Transparent, colorless, amorphous copolyamides and molded articles made therefrom | EMS INVENTA AG (CH) | 2001-08-21 | — | — | US | disclosed |
| JP-2001115017-A | POLYAMIDE RESIN COMPOSITION | MITSUBISHI GAS CHEM CO INC | 2001-04-24 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12597655-B2 | Device for cooling and/or heating a battery of an electric or hybrid motor vehicle | KIF5B, HSPB1, MYO3A | EPHX2 1648/4885NCF1 2690/4885CYP2D6 2844/4885 |
| US-20030191134-A1 | Non-peptide somatostatin receptor ligands | SSTR2, SSTR1, SSTR3 | EPHX2 4673/4885NCF1 3526/4885CYP2D6 3992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.